You are here

  • Home
  • Archive
  • Volume 21, Issue 1
  • Longer dual antiplatelet therapy (DAPT) after percutaneous coronary intervention has higher anti-ischaemic efficacy than shorter DAPT but is associated with more frequent bleeding

Article info

Article menu
Download PDFPDF
Therapeutics/Prevention
Systematic review with meta-analysis
Longer dual antiplatelet therapy (DAPT) after percutaneous coronary intervention has higher anti-ischaemic efficacy than shorter DAPT but is associated with more frequent bleeding

Authors

  • Eliano P Navarese SIRIO 2 Systematic Investigation and Research on Interventions and Outcomes (SIRIO) MEDICINE Research Network and Heinrich-Heine-University, Düsseldorf, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to : Dr Eliano P Navarese, Division of Cardiology, Pulmonology and Vascular Medicine, Department of Internal Medicine, Heinrich-Heine-University, Moorenstr. 48, Düsseldorf 40225, Germany; elianonavarese{at}gmail.com
View Full Text

Citation

Navarese EP
Longer dual antiplatelet therapy (DAPT) after percutaneous coronary intervention has higher anti-ischaemic efficacy than shorter DAPT but is associated with more frequent bleeding
BMJ Evidence-Based Medicine 2016;21:16.

Publication history

  • First published October 21, 2015.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/